Physicians prescribe 5% more cancer drugs following a pharmaceutical representitive's visit, but the practice does not appear to affect cancer patients' mortality, NPR reported April 22.

University of Pittsburgh Medical Center researchers found a way to predict when a rare eye cancer will respond to treatment, The Washington Post reported April 22.

The National Cancer Institute recognized Philadelphia-based Jefferson Health's Sidney Kimmel Cancer Center as a comprehensive cancer center.

The implementation of IT solutions that pull physicians away from patients and moving profits to payer groups are two issues that concern John Montville, executive director of the oncology service line at Mercy Health-Lourdes Hospital in Paducah, Ky.

Bin Zheng, PhD, who specializes in targeted therapies and immunotherapy, was appointed director of melanoma research in the Department of Biomedical Sciences at Los Angeles-based Cedars-Sinai Cancer.

A growing body of research shows cancer rates are on the rise in adults younger than 50. In response, many oncologists have pointed to the need for more awareness across the healthcare continuum, stronger care coordination on the primary care side to ensure early detection and treatment, and continued research investments to pinpoint what's behind rising rates. 

Houston-based University of Texas MD Anderson Cancer Center has partnered with CureVac, a global biopharmaceutical company, to develop novel mRNA-based cancer vaccines.

Medicare reimbursement for common breast cancer surgeries have declined significantly over the last 20 years, a new study from researchers at the Fox Chase Cancer Center and Temple University Hospital, both based in Philadelphia, found.

Eighteen percent of oncologists said their burnout is so severe that they may leave medicine, according to a Medscape report.

Columbus-based Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital found that the "concerning rise" in nonsmoking lung cancer cases could be due to radon gas.

St. Mary's Health System will close its oncology practice, St. Mary's Center For Cancer and Blood Disorders, on July 1, ABC affiliate WMTW reported April 12.

Cancer patients participating in treatment trials is twice as high than historical estimates, a recent study found.

Cleveland Clinic Cancer Institute is partnering with Egg Harbor Township, N.J.-based AtlantiCare Cancer Institute to expand access to advanced research, clinical trials and cancer treatment for AtlantiCare patients.

The funding bill for the National Cancer Institute and the National Institutes of Health have been finalized, leaving the NCI with $96 million less than its fiscal year 2023 total enacted budget but $120 million more compared to the base budget.

New York Jets quarterback Aaron Rodgers pledged $3 million toward Enloe Health's upcoming comprehensive cancer center in Chico, Calif., the Enterprise-Record reported April 9.

Boston-based Dana-Farber Cancer Institute has retracted an additional study in the midst of an investigation into research that may include manipulated or duplicated images, NBC News reported April 9.

Accelerated biological aging may be a factor in rising cancer rates among younger adults, new findings from researchers at the Washington University School of Medicine in St. Louis suggest. 

By 2050, new cancer diagnoses are expected to reach 35 million worldwide — up from the 20 million cases diagnosed in 2022, according to the American Cancer Society's 2024 report on global cancer statistics. 

A recent study by researchers at Brigham and Women's Hospital and Harvard Medical School, both based in Boston, found only 43% of cancer drugs granted accelerated FDA approval demonstrated clinical benefit in confirmatory trials.

Los Angeles-based Keck Medicine of USC will assess the feasibility of providing home-based immunotherapy to patients with non-small cell lung cancer via a new clinical trial.